Navigation Links
Myoglobin EIA Lipid / Protein Quantification, Cardiovascular 024-IDC-13 Muscle Disease

ProductsMyoglobin EIA Lipid / Protein Quantification, Cardiovascular 024-IDC-13 Muscle Disease
Company ALPCO Diagnostics
Item Myoglobin EIA Lipid / Protein Quantification, Cardiovascular 024-IDC-13 Muscle Disease
Features 
Description Myoglobin EIA Lipid / Protein Quantification, Cardiovascular 024-IDC-13 Muscle Disease
Info ALPCO DiagnosticsCall ALPCO Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-466-7731

Customer Service: (800) 592-5726
Web site: http://www.alpco.com

Related medicine products :

1. Myoglobin RIA Lipid / Protein Quantification, Cardiovascular 024-IDC-11 Muscle Disease
2. Human Myoglobin Enzyme Immunoassay
3. Myoglobin ELISA
4. Myoglobin IRMA Kit
5. Myocardial Infarction - Myoglobin and Troponin Cassette
6. Myoglobin Assay for the VITROS ECi Immunodiagnostic System
7. CARDIAC M Myoglobin
8. AxSYM Myoglobin
9. Acute Care Myoglobin TestPak
10. Myoglobin Immunoassay Kit
11. Myoglobin Test Modules
Troponin I EIA Hypertension/ Cardiac Evaluation 025-BC-1105
IGF-BP3 EIA Endocrine Function 022-IGF-E03 Insulin Growth Factor binding protein
Human Growth Hormone EIA Endocrine Function 025-BC-1033
...e enzyme immunoassay. It is based on the direct s...es are directed against separate antigenic determi...ation, insulin in the sample reacts with peroxidas...lin antibodies bound to the microplate wells. A s...
Medicine Products:
(Date:8/8/2008)...ean of the Harvard School of Public Health, today ... Iranian authorities of Dr. Kamiar Alaei, a 2007 M...is brother, Dr. Arash Alaei. The brothers are Iran...ment of HIV/AIDS, an important public health probl... their welfare, as their whereabouts are unknown, ...
(Date:8/7/2008)...hildren,s Hospital & Research Center Oakland conti...ith the creation of a new medical journal focused ...H, Medical Director of Children,s Pediatric Rehabi...chief of the Journal of Pediatric Rehabilitation ...terly journal released its second issue in July 20...
(Date:8/7/2008)...IDs, lacked basic ethical standards, study finds ,...Blogs written by medical professionals may pose a ...the blogs may inadvertently reveal patient informa...e the issue. , The researchers analyzed the con...cent contained enough information to reveal the au...
(Date:8/7/2008)...es in consumer decision-making and,consumer health...ctrum, WASHINGTON, Aug. 7 /PRNewswire-USNewswire/...tion,s foremost thought leaders in health care,man...ices in Health Care,Consumer Empowerment and Prote...innovative and proven programs from health informa...
Breaking Medicine News(10 mins):Health News:Children's Hospital Oakland publishes first of its kind pediatric rehabilitation journal 2Health News:Medical Blogs May Threaten Patient Privacy 2Health News:URAC Reveals Distinguished Judges' Panel for 2009 Best Practices in Health Care Consumer Empowerment and Protection Awards 2Health News:URAC Reveals Distinguished Judges' Panel for 2009 Best Practices in Health Care Consumer Empowerment and Protection Awards 3
...ctors, all newborns should be vaccinated against ... against possible disease from infected mothers.Pr...ommended only for newborns// whose mothers were kn...known.The new recommendation is listed in the chil...
...e FDA issued a statement about the potential for d...g, Accutane. And now, reports say that the 15-year... was prescribed the drug. At this point, investiga... J. Bishop, was actually taking Accutane at the ti...
...consumption of alcohol, which has already been sho...also ward off Alzheimer's disease and other types ...t seem to matter what people drink - the effect is...cohol consumption between one and three drinks a d...
... sleuths found that the absence of a certain prote...its water levels.Reported in the New England journ...idney works.// The protein aquaporin-1has a def...g of the kidneys",says Landon King,lead author of ...
Other Medicine News:Health News:Babies Need Vaccination 2
(Date:8/5/2008)...BRIDGE, Mass., Aug. 5 /- Tolerx, Inc....very and development of novel,therapies for the tr...ay,that Genentech, a collaborator, has moved a mod...clonal antibody, into a phase 1 clinical trial,tha... is evaluating the,safety and tolerability of both...
(Date:8/5/2008)...Clinical study planned for advanced or recurrent s...FirstCall/ -- Medarex, Inc.,(Nasdaq: MEDX ) annou... drug,application (IND) filed with the U.S. Food &...reatment of patients with selected advanced or rec...noma, melanoma, non-small cell,lung cancer or epit...
(Date:8/5/2008)...-Term Clinical Study Confirms Effectiveness of Aut...RNewswire/ -- The results of a two-year,representa...e,internationally renowned journal "Osteoarthritis...ess of Orthokine therapy, in which,anti-inflammato...are,injected into the arthritic joint., Researche...
(Date:8/5/2008)...MOUTH JUNCTION, N.J., Aug. 5 /- Micro... that the first clinical milestone in its,collabor...liate, has been,achieved, triggering the first pay...ose,s dry powder inhaler (DPI) technology announce...tion by Merck of a Phase I clinical,study of an in...
Breaking Medicine Technology:Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 3Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-PD-L1 Antibody, MDX-1105 2Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-PD-L1 Antibody, MDX-1105 3Orthokine Treatment is Effective for Knee Arthritis, Even After Two Years 2MicroDose Technologies Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under Collaboration with Merck & Co., Inc. 2BioSpace and the Massachusetts Biotechnology Council Launch 2008 Genetown 28TM 29 Hotbed Campaign 2545 1BioSpace and the Massachusetts Biotechnology Council Launch 2008 Genetown 28TM 29 Hotbed Campaign 2545 2Transgenes Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non Small Cell Lung Cancer 2541 1Transgenes Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non Small Cell Lung Cancer 2541 2Transgenes Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non Small Cell Lung Cancer 2541 3Biofuels Sustainability 1842 1Biofuels Sustainability 1842 2Biofuels Sustainability 1842 3Protein in human hair shows promise for regenerating nerves 9372 1Protein in human hair shows promise for regenerating nerves 9372 2Protein in human hair shows promise for regenerating nerves 9372 3
...sponse and Remission in,Follow-up to Phase 1 and P...atients with IV Steroid-Refractory Ulcerative Coli...stCall/ -- Data,presented at the Digestive Disease...y Dr. William Sandborn from the Mayo Clinic,sugges...pment as a,treatment for intravenous steroid-refra...
...007 - BioLineRx Ltd.,(TASE:BLRX), Israel,s leading...m its Phase I trial of BL-1020, the first GABA,enh...atment of,schizophrenia. The trial demonstrated th...d biochemical evidence of dopamine,blockade which ...,data in a poster (Abstract 235 XX) at the 2007 Am...
Other Medicine Technology:PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 2PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 3PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 4PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 5BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 2BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 3BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 4